We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.59B
AUM Growth
+$283M
Cap. Flow
+$228M
Cap. Flow %
14.35%
Top 10 Hldgs %
6.1%
Holding
1,532
New
540
Increased
294
Reduced
266
Closed
432

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$11.9M
2
BMO icon
Bank of Montreal
BMO
+$10.5M
3
HPQ icon
HP
HPQ
+$9.75M
4
AER icon
AerCap
AER
+$9.53M
5
ITW icon
Illinois Tool Works
ITW
+$8.27M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$8.73M
2
SYF icon
Synchrony
SYF
+$8.42M
3
CAH icon
Cardinal Health
CAH
+$7.63M
4
BRO icon
Brown & Brown
BRO
+$7.55M
5
UL icon
Unilever
UL
+$7.37M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Financials 17.36%
3 Industrials 17.08%
4 Consumer Discretionary 12.43%
5 Healthcare 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
1326
Medtronic
MDT
$117B
-34,748
Closed -$3.12M
MED icon
1327
Medifast
MED
$131M
-14,420
Closed -$194K
MEOH icon
1328
Methanex
MEOH
$4.18B
-18,566
Closed -$651K
MET icon
1329
MetLife
MET
$61.9B
-12,497
Closed -$1M
MGEE icon
1330
MGE Energy Inc
MGEE
$3.09B
-13,059
Closed -$1.21M
MHO icon
1331
M/I Homes
MHO
$3.87B
-12,670
Closed -$1.45M
MIR icon
1332
Mirion Technologies
MIR
$3.84B
-33,425
Closed -$485K
MIRM icon
1333
Mirum Pharmaceuticals
MIRM
$6.07B
-25,944
Closed -$1.17M
MRSH
1334
Marsh
MRSH
$90.4B
-7,254
Closed -$1.77M
MOD icon
1335
Modine Manufacturing
MOD
$10.8B
-2,965
Closed -$228K
MOH icon
1336
Molina Healthcare
MOH
$10.8B
-4,897
Closed -$1.61M
MPC icon
1337
Marathon Petroleum
MPC
$98.5B
-2,145
Closed -$313K
MRVL icon
1338
Marvell Technology
MRVL
$205B
-36,931
Closed -$2.27M
MS icon
1339
Morgan Stanley
MS
$348B
-5,105
Closed -$596K
MT icon
1340
ArcelorMittal
MT
$55.7B
-58,209
Closed -$1.68M
MTD icon
1341
Mettler-Toledo International
MTD
$28.6B
-481
Closed -$568K
MTRN icon
1342
Materion
MTRN
$5.91B
-8,133
Closed -$664K
MTSI icon
1343
MACOM Technology Solutions
MTSI
$24.1B
-4,230
Closed -$425K
MTX icon
1344
Minerals Technologies
MTX
$2.27B
-4,353
Closed -$277K
MXL icon
1345
MaxLinear
MXL
$7.05B
-16,223
Closed -$176K
NCLH icon
1346
Norwegian Cruise Line
NCLH
$8.82B
-88,974
Closed -$1.69M
NCNO icon
1347
nCino
NCNO
$2.13B
-30,333
Closed -$833K
NDSN icon
1348
Nordson
NDSN
$17.2B
-3,173
Closed -$640K
NEE icon
1349
NextEra Energy
NEE
$180B
-50,352
Closed -$3.57M
NEM icon
1350
Newmont
NEM
$121B
-22,646
Closed -$1.09M

Similar funds

Campbell & Co Investment Adviser's Q2 2025 Portfolio in Review

As of Q2 2025, Campbell & Co Investment Adviser held 1,532 positions worth $1.59B, up 22% from $1.3B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Campbell & Co Investment Adviser deployed $228M of net new capital in Q2 2025, opening 540 new positions and adding to 294 existing holdings. Its largest new stake was Johnson Controls International: 128,951 shares worth $13.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 9.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cardinal Health, an estimated $7.63M trimmed.

  • Campbell & Co Investment Adviser's largest Q2 2025 buy was Johnson Controls International: 128,951 shares worth $13.6M.
  • Campbell & Co Investment Adviser added most to Dover in Q2 2025, an estimated $7.63M increase.
  • Campbell & Co Investment Adviser's biggest Q2 2025 reduction was Cardinal Health, cutting an estimated $7.63M.
  • Campbell & Co Investment Adviser fully exited Labcorp in Q2 2025, selling an estimated $8.73M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6.1% of its $1.59B portfolio in Q2 2025.
  • Campbell & Co Investment Adviser opened 540 new positions and closed 432 in Q2 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 22% quarter-over-quarter to $1.59B.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.